Company: IXHL
Filing Date: 2025-05-28
Form Type: 8-K
Source: 0001213900-25-047988
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-05-28
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

Amended and Restated ATM Sales Agreement

As previously reported, on
April 7, 2025 Incannex Healthcare Inc. (the “ Company”) entered into a Sales Agreement with A. G. P./Alliance Global Partners
as sales agent for the Company’s “at the market offering” program. On May 27, 2025, the Company entered into an Amended
and Restated Sales Agreement (the “ Amended and Restated Sales Agreement”) by and among the Company, A. G. P./Alliance Global
Partners and Curvature Securities, LLC (“ Curvature”) to add Curvature as an additional sales agent (together, the “ Sales
Agents”) and to make certain conforming changes.

The representations, warranties
and covenants contained in the Amended and Restated Sales Agreement were made solely for the benefit of the parties to the Amended and
Restated Sales Agreement and may be subject to limitations agreed upon by the contracting parties. Accordingly, the Amended and Restated
Sales Agreement is incorporated herein by reference only to provide investors with information regarding the terms of the Amended and
Restated Sales Agreement and not to provide investors with any other factual information regarding the Company or its business, and should
be read in conjunction with the disclosures in the Company’s periodic reports and other filings with the U. S. Securities and Exchange
Commission.

The foregoing description
of the Amended and Restated Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full
text of the Amended and Restated Sales Agreement, which is filed as Exhibit 1.1 hereto and is incorporated by reference herein.

Also on May 27, 2025,
the Company filed a prospectus supplement to increase the amount of shares of the Company’s common stock, par value $0.0001
per share (the “ Shares”), issuable pursuant to the Amended and Restated Sales Agreement, to up to an aggregate of an
additional $50,000,000 of Shares. Subject to certain limitations in the Amended and Restated Sales Agreement, agreements with
existing investors and compliance with applicable law, the Company has the discretion (and not the obligation) to deliver placement
notices to the Sales Agents to sell shares of its common stock at any time throughout the term of the Amended and Restated Sales
Agreement. There can